| |
α
|
M
|
SD
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9.1
|
9.2
|
9.3
|
|---|
|
1. Age
| |
61.88
|
8.92
| | | | | | | | | | | |
|
2. BMI
| |
30.78
|
6.49
|
−0.30***
| | | | | | | | | | |
|
3. Intrinsic regulation
|
0.95
|
4.34
|
1.63
|
0.14
|
−0.24***
| | | | | | | | | |
|
4. Identified regulation
|
0.80
|
4.98
|
1.16
|
0.21*
|
−0.25***
|
0.66***
| | | | | | | | |
|
5. Introjected regulation
|
0.77
|
2.43
|
1.65
|
0.02
|
0.09
|
−0.04
|
0.14
| | | | | | | |
|
6. External regulation
|
0.85
|
1.44
|
1.62
|
−0.03
|
0.26***
|
−0.23***
|
− 0.22***
|
0.34***
| | | | | | |
|
7. Amotivation
|
0.59
|
0.50
|
0.8
|
0.03
|
0.16*
|
−0.27***
|
−0.26***
|
0.16
|
0.54***
| | | | | |
|
8. Weekly MVPA
| |
129.71
|
115.80
|
0.02
|
−0.29***
|
0.29***
|
0.11
|
−0.16
|
−0.35***
|
− 0.22***
| | | | |
|
T2D acute symptoms
|
|
9.1. Fatigue
|
0.82
|
2.05
|
1.03
|
−0.15
|
0.17*
|
−0.23***
|
− 0.16*
|
0.04
|
0.01
|
−0.10
|
− 0.26***
| | | |
|
9.2. Cognitive distress
|
0.81
|
1.80
|
0.92
|
−0.15
|
0.09
|
−0.22*
|
− 0.23***
|
0.00
|
− 0.02
|
−0.10
|
− 0.20*
|
0.75***
| | |
|
9.3. Hypoglycemia
|
0.78
|
1.67
|
0.88
|
−0.06
|
0.01
|
−0.12
|
− 0.12
|
0.07
|
0.04
|
0.01
|
−0.07
|
0.44***
|
0.56***
| |
|
9.4. Hyperglycemia
|
0.81
|
1.97
|
1.00
|
0.07
|
0.16*
|
−0.09
|
−0.08
|
0.09
|
0.10
|
0.09
|
−0.19*
|
0.40***
|
0.53***
|
0.50***
|
- Weekly MVPA; over the entire period the accelerometer was worn, average number of minutes spent practicing MVPA per week
- *p < 0.05, ***p < 0.001
